檢索結果 - Twelves, Chris

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis 由 Cortes, Javier, Twelves, Chris

獲取全文 獲取全文 獲取全文

Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework 由 Saini, Kamal S., Twelves, Chris

獲取全文 獲取全文 獲取全文

Maximum a posteriori Bayesian estimation of epirubicin clearance by limited sampling 由 Ralph, Lorraine D, Thomson, Alison H, Dobbs, Nicola A, Twelves, Chris

獲取全文 獲取全文 獲取全文

Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study 由 Thomson, Catherine S, Woolnough, Sarah, Wickenden, Matthew, Hiom, Sara, Twelves, Chris J

獲取全文 獲取全文 獲取全文

Assessment of the validity of a population pharmacokinetic model for epirubicin 由 Ralph, Lorraine D, Sandstrom, Marie, Twelves, Chris, Dobbs, Nicola A, Thomson, Alison H

獲取全文 獲取全文 獲取全文

Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records 由 Macleod, Una, Ross, Sue, Twelves, Chris, George, W D, Gillis, Charles, Watt, Graham C M

獲取全文 獲取全文

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies 由 Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad

獲取全文 獲取全文 獲取全文

Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam 由 Perkins, Everett J., Posada, Maria, Kellie Turner, P., Chappell, Jill, Ng, Wee Teck, Twelves, Chris

獲取全文 獲取全文 獲取全文

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma 由 Twelves, Chris, Sabel, Michael, Checketts, Daniel, Miller, Sharon, Tayo, Bola, Jove, Maria, Brazil, Lucy, Short, Susan C.

獲取全文 獲取全文 獲取全文

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis 由 O’Shaughnessy, Joyce, Cortes, Javier, Twelves, Chris, Goldstein, Lori J., Alexis, Karenza, Xie, Ran, Barrios, Carlos, Ueno, Takayuki

獲取全文 獲取全文 獲取全文

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer 由 Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.

獲取全文 獲取全文 獲取全文

Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer 由 Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O’Shaughnessy, Joyce

獲取全文 獲取全文 獲取全文

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracyclin... 由 Kaufman, Peter A., Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A., Velikova, Galina, Olivo, Martin S., He, Yi, Dutcus, Corina E., Cortes, Javier

獲取全文 獲取全文 獲取全文

Effect of Adjuvant Capecitabine or Fluorouracil, with or without Oxaliplatin, on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival:... 由 Schmoll, Hans-Joachim, Twelves, Chris, Sun, Weijing, O'Connell, Michael J, Cartwright, Thomas, McKenna, Edward, Saif, Muhammad, Lee, Steve, Yothers, Greg, Haller, Daniel

獲取全文 獲取全文 獲取全文

Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre 由 Twelves, Chris, Cheeseman, Sue, Sopwith, Will, Thompson, Matthew, Riaz, Majid, Ahat-Donker, Necibe, Myland, Melissa, Lee, Adam, Przybysz, Raymond, Turner, Stuart, Hall, Geoff, Perren, Tim

獲取全文 獲取全文 獲取全文

Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro 由 Hawsawi, Yousef, Humphries, Matthew P., Wright, Alexander, Berwick, Angelene, Shires, Mike, Al-Kharobi, Hanaa, El-Gendy, Reem, Jove, Maria, Twelves, Chris, Speirs, Valerie, Beattie, James

獲取全文 獲取全文 獲取全文

CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial 由 Coleman, Rob, Brown, Janet, Rathbone, Emma, Flanagan, Louise, Reid, Amber, Kendall, Jessica, Howell, Sacha, Twelves, Chris, Palmieri, Carlo, Anand, Anjana, MacPherson, Iain, Brown, Sarah

獲取全文 獲取全文 獲取全文

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine 由 Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry

獲取全文 獲取全文 獲取全文

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial 由 Franzoi, Maria Alice, Procter, Marion, Twelves, Chris, Ponde, Noam, Eiger, Daniel, Emond, Orianne, Clark, Emma, Parlier, Damien, Guillaume, Sébastien, Reaby, Linda, de Azambuja, Evandro, Bines, Jose

獲取全文 獲取全文 獲取全文

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases 由 Tripathy, Debu, Tolaney, Sara M, Seidman, Andrew D, Anders, Carey K, Ibrahim, Nuhad, Rugo, Hope S, Twelves, Chris, Dieras, Veronique, Müller, Volkmar, Tagliaferri, Mary, Hannah, Alison L, Cortés, Javier

獲取全文 獲取全文 獲取全文